November 20 coronavirus news | CNN

November 20 coronavirus news

Dr. Deborah Brix
Dr. Birx: Keep Thanksgiving to your immediate household
02:19 - Source: CNN

What you need to know

  • The US has reported more than 193,000 new Covid-19 cases so far on Friday — a record one-day total for the second day in a row.
  • Pfizer says it has submitted for emergency use authorization from the US Food and Drug Administration for its coronavirus vaccine.
  • An influential model has hiked its forecast of US Covid-19 deaths considerably and now predicts 471,000 people will die from the disease by March 1.
  • India has surpassed 9 million Covid-19 cases, with the capital Delhi seeing a surge in infections.

Our live coverage of the coronavirus pandemic has moved here.

53 Posts

Mask mandates worked to slow the spread of Covid-19 in Kansas, CDC research shows

Fans try to stay warm while also wearing masks and social distancing in the first half of an MLS match between the Colorado Rapids and Sporting Kansas City on October 24 at Children's Mercy Park in Kansas City, KS.

While they may be unpopular in some places, mask mandates work to slow the spread of Covid-19, according to new research published Friday by the US Centers for Disease Control and Prevention.

Since Covid-19 spreads predominantly through respiratory droplets, wearing a mask can protect others from the person wearing the mask who may have Covid-19. This month, the CDC released guidance that said masks can protect the wearer, too, by filtering incoming infectious droplets.

On July 2, as Covid-19 cases were surging in the state, Kansas Gov. Laura Kelly signed an executive order that made masks mandatory in public spaces. The majority of the state’s counties, 81, opted out of this executive order, but 24 opted in or created their own mask mandate. The counties that did require masks account for two-thirds of Kansas’ population.

The CDC and the Kansas Department of Health and Environment looked at the Covid-19 case trends between June 1 and July 2, before the mandate, and then July 3 to August 23, after the mandate, to compare what happened.

In the 24 counties that required people to wear masks in public, there was a net decrease of 6% in cases; whereas the disease continued to surge in the counties without the mandate. In those counties, the net increase in cases was 100%.

Read more:

KANSAS CITY, KS - OCTOBER 24: A Sporting Kansas City fan wears a mask and tries to stay warm on a cold night on October 24, 2020 at Children's Mercy Park in Kansas City, KS.  (Photo by Scott Winters/Icon Sportswire via Getty Images)

Related article Masks mandates worked to slow the spread of Covid-19 in Kansas, CDC research shows

Lack of shared information between Trump and Biden teams is "dangerous," says Biden virus advisory board member

Director of the Center for Infectious Disease Research and Policy at the University of Minnesota, Michael Osterholm.

It is “critical” that US President Donald Trump’s administration share important information about coronavirus response and vaccine distribution with President-elect Joe Biden’s team, Michael Osterholm, a member of Biden’s coronavirus advisory board, said Friday.

Current coronavirus vaccine distribution plans are still preliminary and mainly focus on rolling out the first doses to health care workers, Osterholm told CNN’s Erin Burnett.

Osterholm, who is director of the Center for Infectious Disease Research and Policy at the University of Minnesota, noted that vaccine hesitancy will be a major roadblock to successful vaccination. 

“This is why we have to today, begin working very, very hard at a community grassroots level to help communities understand why they want this,” he said.

The US has reported more than 193,000 cases so far today -- a new daily high for the second straight day

A healthcare worker administers a free Covid-19 test to a person in a car at the Columbus West Family Health and Wellness Center in Columbus, Ohio on November 19.

The United States has reported 193,079 Covid-19 cases so far on Friday, according to Johns Hopkins University, the highest one-day total of the pandemic for a second consecutive day.

The previous daily high was recorded on November 19, with 187,833 cases.

At least 11,908,395 Covid-19 cases, including 254,383 deaths, have now been reported nationwide.

The totals include cases from all 50 states, the District of Columbia and other US territories, as well as repatriated cases.

Note: The numbers are not the final count for the day, and could rise further.

CNN is tracking the US cases:

Canada's largest city is going into lockdown for at least 28 days

Shoppers walk through the Eaton Centre in Toronto on November 20. Retail will be allowed to operate for curbside pick-up or delivery only under lockdown rules that take effect Monday.

Toronto, Canada’s biggest city, is going into lockdown for at least 28 days to limit the spread of Covid-19, according to a news release from the Office of the Premier of Ontario published Friday. 

The lockdown will go into effect Monday and it includes Peel Region, which is part of the Greater Toronto Area. 

Ontario Premier Doug Ford said in the news release that Covid-19 numbers are “rising rapidly in certain regions,” adding the lockdown will protect “hospitals, long-term care and retirement homes, and every person in this province.” 

These are the lockdown rules:

  • Indoor social gatherings or events won’t be allowed except with members of the same household, and outdoor gatherings will be limited to no more than 10 people, according to the release. 
  • Wedding services, funerals, and religious ceremonies where physical distancing can be maintained indoors or outdoors will also be limited to no more than 10 people. 
  • Retail will be allowed to operate for curbside pick-up or delivery only. Certain businesses such as grocery stores and pharmacies will be allowed to open at 50% capacity. 
  • Schools and childcare will remain open, and post-secondary education will move to virtual learning except for training that can only be provided in person. 

Other parts of the province will move to higher levels of restrictions starting Monday as well, according to the release. 

Washington governor says "the house is on fire" when it comes to Covid-19 outbreak

Washington Gov. Jay Inslee speaks during a news conference on Nov. 15, at the Capitol in Olympia, Washington.

Washington Gov. Jay Inslee says he and other state leaders have had no choice about putting tighter Covid-19 restrictions in place this week given the size of the pandemic.

This week, the state prohibited indoor gatherings with people outside the organizer’s own household unless they quarantine ahead of the event, and get a negative Covid-19 test within 48 hours. Indoor service in restaurants is prohibited. The restrictions will last until at least December 14.

To address concerns of businesses being closed again, Inslee announced that the state is releasing another $135 million in leftover CARES Act money, $70 million of which is earmarked for business grants.

But Inslee added this is probably the last stimulus the state will be able to scrape together without more assistance from the federal government. “We are nearing a cliff of support from the federal government for Washingtonians,” he said.

Almost a million people have been given an experimental Chinese coronavirus vaccine, pharma giant claims

Almost a million people have been given an experimental coronavirus vaccine developed by Sinopharm as part of an emergency-use program authorized by Beijing, the Chinese pharmaceutical giant’s chairman said.

No serious adverse effects have been reported from vaccine recipients so far, Sinopharm said Wednesday in an article on social media platform WeChat, citing Chairman Liu Jingzhen.

Liu said the vaccine had been given to Chinese construction workers, diplomats, and students who have gone to more than 150 countries during the pandemic – and none of them has reported an infection.

He said on November 6 that there were 56,000 people who had received emergency vaccinations and then gone overseas.

“For example, a transnational company has 99 employees in one of its overseas offices, of whom 81 were vaccinated. And later, an outbreak broke out in the office, 10 of the 18 people who were not vaccinated were infected and none of those vaccinated were infected,” he said.

Read the full story:

BEIJING, March 16, 2020.A staff member displays samples of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd., in Beijing, capital of China, March 16, 2020. China has approved two COVID-19 inactivated vaccine candidates for clinical trials, according to the State Council joint prevention and control mechanism against the coronavirus Tuesday.
   The two vaccine candidates are developed by Wuhan Institute of Biological Products under the China National Pharmaceutical Group ,Sinopharm, and Sinovac Research and Development Co., Ltd, a company based in Beijing. Clinical trials of the two vaccines have started. (Photo by Zhang Yuwei/Xinhua via Getty) (Xinhua/Zhang Yuwei via Getty Images)

Related article Almost a million people have been given an experimental Chinese coronavirus vaccine

Donald Trump Jr. tests positive for coronavirus

Donald Trump Jr. attends a book signing to promote his book "Liberal Privilege"in Long Island, New York, on Sunday, October 18.

President Trump’s son, Donald Trump Jr., has tested positive for Covid-19, his spokesperson said.

Bloomberg first reported the story. 

FDA announces advisory committee to meet to discuss Pfizer's vaccine application in December

The US Food and Drug Administration said Friday it has scheduled a meeting of its outside advisory panel to discuss Pfizer and BioNTech’s application for emergency use authorization for a coronavirus vaccine.

The Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet on Dec. 10. 

The companies submitted their application for an EUA earlier Friday. It’s the first application for an FDA regulatory OK for a coronavirus vaccine.

“The FDA has been preparing for the review of EUAs for Covid-19 vaccines for several months and stands ready to do so as soon as an EUA request is submitted. While we cannot predict how long the FDA’s review will take, the FDA will review the request as expeditiously as possible, while still doing so in a thorough and science-based manner, so that we can help make available a vaccine that the American people deserve as soon as possible.”

The FDA is supposed to post the VRBPAC meeting schedule in the Federal Register at least two weeks ahead of time. The agency has promised to fully consider input from the committee, which is made up of vaccine experts and others with no ties to the companies submitting vaccines for FDA approval or authorization.

The FDA said it will livestream the VRBPAC meeting on the agency’s YouTube, Facebook and Twitter channels and from the FDA website.

Regeneron has had discussions with Biden's team about Covid-19 antibody treatment

The president of the company that makes the monoclonal antibody treatment given to President Trump says his company has been speaking with President-elect Joe Biden’s transition team.

Regeneron has applied for emergency use authorization for its antibody treatment for coronavirus, but is still waiting for a decision from the US Food and Drug Administration.

“I know that they have a lot of sophistication, and they have tremendous interest of course in all these approaches, including these antibody treatments. They want to know all about them,” Yancopoulos said at a conference sponsored by Reuters.

He added that Regeneron has presented its latest data to Biden’s team.

“Biden has always been a pro-science guy, so of course we’re hopeful that they’re going to take a careful and a data-based approach, and try to do the best to figure out how to best deliver the available therapies and vaccines to the people who might benefit the most,” Yancopoulos said. 

Scotland bans all nonessential travel to England

Cars pass a Covid warning sign on the eastbound M8 motorway in Glasgow ahead of the introduction of further coronavirus restrictions on Friday, November 20.

Scotland on Friday banned all nonessential travel across the border to England, Scottish First Minister Nicola Sturgeon confirmed in her daily briefing.

The new law came in to force at 6 p.m. local time on Friday (1 p.m. ET), anyone caught breaking the rules could face a fine of around $80.

Travel to Wales, Northern Ireland and the Republic of Ireland is also prohibited, unless for essential reasons. 

However, people living under restriction levels zero to two — which includes the Scottish Borders region — are technically still allowed to travel overseas for a holiday. Starting Friday it will be an offense for those living under tiers three and four to leave their local area.  

It was announced on Tuesday that over two million people in 11 areas in the west of Scotland — including Glasgow, the country’s largest city — will move into the highest level of restrictions starting Friday. 

This will see nonessential shops, cafes and gyms close for at least three weeks. Bars, pubs and restaurants in most of these areas have been closed since Oct. 9, and people can only meet with one other household in an outdoor setting. 

Sturgeon also confirmed that on Friday Scotland registered 1,018 new cases of Covid-19 and 32 deaths, bringing the country’s total figures since the start of the pandemic to 86,630 confirmed cases and 3,459 deaths.

Authorities in England are yet to say if they will reciprocate the cross-border travel ban.

Eli Lilly's monoclonal antibody for Covid-19 gets interim approval in Canada

Eli Lilly’s monoclonal antibody treatment for Covid-19, bamlanivimab, got interim authorization from Health Canada Friday, according to a company news release.

The treatment is approved for use in Canada in adults and children older than 12 with a mild to moderate case of Covid-19 who are at high risk of progressing to more severe disease.

This is the second authorization for bamlanivimab. The US Food and Drug Administration gave it an emergency use authorization Nov. 9.

The treatment was created through a partnership with the help of the Canadian biotechnology company AbCellera.

Brazil surpasses 6 million Covid-19 cases

A container carrying the experimental COVID-19 vaccine CoronaVac is unloaded from a cargo plane that arrived from China at Guarulhos International Airport in Guarulhos, near Sao Paulo, Brazil, on Thursday, November 19.

Brazil has surpassed 6 million cases of Covid-19, making it the third country to hit this milestone after the United States and India.

Brazil registered 38,397 new infections Friday, raising the total number of cases to 6,020,164, according to data released by the health ministry.

The country registered 552 more deaths on Friday, bringing the total to 168,613.

Last week, Brazil’s President Jair Bolsonaro dismissed the high number of Covid-19 deaths, saying “we will all die one day.”

California sets new daily record for Covid-19 infections

Lines of vehicles make their way to and from Dodger Stadium for Covid-19 testing on Friday, November 20, in Los Angeles.

California reported 13,005 new coronavirus cases on Friday, shattering the state’s record for the most new cases in a single day since the start of the pandemic.

The unprecedented number of new infections surpassed the state’s previous peak of 12,807 reported in July when California last experienced a surge in cases.

An additional 91 deaths were also reported Friday, bringing the state’s total to 18,557 Covid-19-related fatalities. 

The 14-day positivity rate in California has climbed to 5.2%, more than double what it was in mid-October. An average of about 166,000 tests are being conducted in the state each day.

The number of newly-admitted patients have far exceeded the two-week hospitalization average of 4,329. On Friday, the state reported an additional 178 patients hospitalized with Covid-19 for a total of 5,497. The number of available intensive care unit beds is waning slightly, with just over 1,900 beds currently vacant.

Gov. Gavin Newsom and health officials have implored residents to avoid gatherings and are implementing an overnight curfew for the vast majority of the state beginning Saturday. Officials are also urging residents not to travel for the upcoming holidays.

Note: These numbers were released by the California Department of Public Health and may not line up exactly in real time with CNN’s database drawn from Johns Hopkins University and the Covid Tracking Project. 

Johnson & Johnson expects to have efficacy results on its Covid-19 vaccine by early 2021

Johnson & Johnson expects to have an efficacy readout on its coronavirus vaccine by January or February of 2021, Dr. Paul Stoffels, the company’s chief scientific officer, said Thursday.

“The efficacy endpoint should be there in the first few weeks or months, January or February, in the new year,” Stoffels said at a conference sponsored by Reuters called the Reuters Total Health Conference.

Stoffels said the company is recruiting upwards of 1,000 people a day for its vaccine clinical trial and expects to reach its goal of 60,000 participants by the end of the year.

Stoffels said Johnson & Johnson is also working hard to meet diversity goals for its clinical trial.

Johnson & Johnson paused its trial in October due to an unexplained illness in a participant. Stoffels the independent Data Safety and Monitoring Board determined that illness was not related to the vaccine, and the company has not had any unexpected events since.

“The DSMB is looking very closely,” he added. “We have regular reviews on the safety, and so far, so good.”

Pfizer and BioNTech file with FDA for emergency authorization for their coronavirus vaccine

A health worker injects a person during Pfizer clinical trials for a Covid-19 vaccine in Hollywood, Florida, on September 9.

Pfizer and BioNTech have submitted to the US Food and Drug Administration for emergency use authorization for their coronavirus vaccine candidate.

This is the first coronavirus vaccine to seek a regulatory OK in the United States. Pfizer and BioNTech said a statement Friday that their vaccine candidate, known as BNT162b2, will potentially be available for use in high-risk populations in the United States by the middle to end of December.

The submission to the FDA is based on results from the Phase 3 clinical trial of Pfizer’s vaccine, which began in the United States on July 27 and enrolled more than 43,000 volunteers. The final analysis from the trial found the coronavirus vaccine was 95% effective in preventing infections, even in older adults, and caused no serious safety concerns, Pfizer and its German partner, BioNTech, announced this week. The submission also includes safety data on about 100 children ages 12 to 15.

About 42% of global participants and 30% of US participants in the Phase 3 study have racially and ethnically diverse backgrounds, the companies said in a news release, and 41% of global and 45% of US participants are ages 56 to 85. 

Another possible vaccine candidate: Moderna, another pharmaceutical company, announced Monday that early results from its clinical trials show their vaccine is 94.5% effective. The company plans to apply to the FDA for authorization after it accumulates more safety data later this month.

The FDA has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee, a group of outside experts, for Dec. 8, 9 and 10, a source familiar with the process told CNN this week. The agency could make a decision at the end of the meeting on Dec. 10 about whether to issue an emergency use authorization, the source said.

Emergency use authorization, or EUA, from the FDA is not the same as full approval. An EUA allows products to be used under particular circumstances before all the evidence needed for approval is available. The agency must determine the product’s “known and potential benefits outweigh its known and potential risks.”

Sister of 12-year-old who died of coronavirus: "If it was not for Covid, my brother would still be here"

A family is mourning the death of 12-year-old Aedan Selph, who died from coronavirus this week — and they have a message for others.

His sister, Evelyn Wolfe, explained that her father is an essential worker and unknowingly brought the virus home.

“We have medically fragile kids in the household, but this really can happen to anybody’s family,” she said in an interview on CNN. “…We want everybody to know that.”

As of Sunday, both her father and Aedan were in the ICU. Her father was released earlier this week, but Aedan’s left lung collapsed on Monday, she said.

Her family, who lives in New Mexico, adopts children who are medically fragile. Aedan was born premature and blind, and the family adopted him and his twin sister when they were 7 months old.

“What I want people to think about is yeah, you might be OK right now, but you don’t know who the person next to you has at home,” she added. 

Wolfe said Aedan loved watching the Kansas City Chiefs with his dad every Sunday.

“He didn’t verbalize the same as we do … His laugh was the most amazing thing. You tell him you love him, he’d just laugh at you. It was amazing,” she said.

Watch:

UK health minister says vaccine could be out by next month

UK Health Minister Matt Hancock speaks during a press conference in London on November 20.

UK Health Minister Matt Hancock said Friday that if the Pfizer/BioNTech vaccine is approved by the UK’s equivalent of the US Food and Drug Administration, it could roll out by next month.

He said that the government has formally asked the Medicines and Healthcare products Regulatory Agency (MRHA), to assess the Pfizer/BioNTech vaccine for its suitability for authorization.

He added if the vaccine will be approved, the government will be ready to start the vaccination next month with the bulk of the roll out in the new year.

Hancock also said that figures from the UK’s Office for National Statistics (ONS) survey that published on Friday are “promising and show that the second peak is flattening.” However, he urged Britons to keep their resolve as there are still many patients in hospitals across the UK and 511 reported deaths as of Friday.

Hancock added it’s too early to decide what happens after the national shutdown is due to end on Dec. 2.

“I am sure we will not be going back to normal after December the 2nd. Further restrictions will be required,” said Professor Stephen H. Powis, England’s National Health Service medical director.

According to the government data published on Friday, there are currently new 20,252 cases and 511 deaths recoded within 28 days of a positive Covid-19. The new number of cases appears to be down from 22,915 cases recorded on Thursday.

CVS chief medical officer says he expects vaccines to be widely available by early spring

Dr. Troy Brennan on November 20.

CVS Health executive vice president and chief medical officer Dr. Troy Brennan said the company is preparing for the massive effort to roll out coronavirus vaccines. 

Brennan said CVS expects to have vaccinations in hand by “mid-December.” They are focusing right now on getting them to nursing homes and assisted living facilities first, in coordination with the White House’s Operation Warp Speed. 

When asked by CNN’s Kate Bolduan when the average person can go in and make an appointment for the first and second vaccine dose, Brennan said “a lot turns on what the FDA does and how quickly they act with the information.”

He expects CVS stores throughout the country to begin offering Covid-19 vaccines by the end of February or beginning of March, and they are prepared to “move rapidly,” he said.

“If you take the other major retailers doing the same thing, you can see very quickly we can build numbers through the spring in terms of number of people who are vaccinated,” he added. 

Watch:

Some testing sites in Illinois are seeing longer wait times, official says

Kevin Jaques, communications director for HRSupport, speaks during an interview on November 20.

The demand has increased at all Covid-19 testing sites in Illinois, said Kevin Jaques, communications director for HRSupport, the company running the state’s Covid-19 testing project.

The surge first began in early October followed by another wave at the beginning of November, he added.

The goal is to test every person in line but the increase in demand affects factors like staffing and partner labs, he told CNN.

“In part, it does make people wait more in lines. It delays the testing results as well,” Jaques said Friday.

As Thanksgiving approaches, Jaques said there is also a concern that people won’t follow the US Centers for Disease Control and Prevention guidelines and take basic precautions like wearing masks and social distancing that help keep the number of new Covid-19 cases down.

“We’re concerned that during the holidays people won’t be following these guidelines as much, and in part, increasing the cases of positivity of Covid-19,” he added.

Watch Kevin Jaques interview here:

cf948b75-439c-4b36-a1cd-e890e3fa05f8.mp4
02:09 - Source: cnn

New York City could close indoor dining and gyms as soon as the week after Thanksgiving

People eat at a restaurant on November 18 in New York City.

New York City Mayor Bill de Blasio reiterated the city could move into the state’s orange zone as soon as the week after Thanksgiving, the mayor said on the WNYC radio show Friday morning.

The mayor said in part, New York City would move in to the orange zoon based on state data, “soon after Thanksgiving probably the first week of December.”

What this means: The orange zone would shut down indoor dining and gyms, according to previous guidelines released by the state. 

New York Gov. Andrew Cuomo will be responsible for making that decision when that time comes, according to officials. 

New York City has a 7-day-test-positivity rate of 3.02%, de Blasio said. The city reports at least 1,307 new cases of the virus, according to city spokesperson Bill Neidhardt.

At least 115 patients have been hospitalized for the virus, Neidhardt said. 

Remember: These numbers were released by the city’s health agency, and may not line up exactly in real time with CNN’s database drawn from Johns Hopkins University and the Covid Tracking Project.

READ MORE

‘This will get worse.’ A top US official says hospitalizations and deaths will keep climbing as Covid-19 cases explode nationwide
While Trump sulks, Americans get sick and die
US military reports record number of coronavirus cases
Inside Mexico’s quest for a homemade vaccine
Pfizer and BioNTech say final analysis shows coronavirus vaccine is 95% effective with no safety concerns

READ MORE

‘This will get worse.’ A top US official says hospitalizations and deaths will keep climbing as Covid-19 cases explode nationwide
While Trump sulks, Americans get sick and die
US military reports record number of coronavirus cases
Inside Mexico’s quest for a homemade vaccine
Pfizer and BioNTech say final analysis shows coronavirus vaccine is 95% effective with no safety concerns